Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
29/01/2026 01:25
Jan 29 (Reuters) - Arovella Therapeutics ALA.AX: IND FOR ALA-101 ACCEPTED BY U.S.FDA Further company coverage: ALA.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO